| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |